223 related articles for article (PubMed ID: 10841514)
21. The serotonin pathway in pulmonary hypertension.
Eddahibi S; Adnot S
Arch Mal Coeur Vaiss; 2006 Jun; 99(6):621-5. PubMed ID: 16878724
[TBL] [Abstract][Full Text] [Related]
22. The serotonin transporter is present and functional in peripheral arterial smooth muscle.
Ni W; Thompson JM; Northcott CA; Lookingland K; Watts SW
J Cardiovasc Pharmacol; 2004 Jun; 43(6):770-81. PubMed ID: 15167270
[TBL] [Abstract][Full Text] [Related]
23. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction.
Coto E; Reguero JR; Alvarez V; Morales B; Batalla A; González P; Martín M; García-Castro M; Iglesias-Cubero G; Cortina A
Clin Sci (Lond); 2003 Mar; 104(3):241-5. PubMed ID: 12605580
[TBL] [Abstract][Full Text] [Related]
24. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
[TBL] [Abstract][Full Text] [Related]
25. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease.
Lawrie A; Spiekerkoetter E; Martinez EC; Ambartsumian N; Sheward WJ; MacLean MR; Harmar AJ; Schmidt AM; Lukanidin E; Rabinovitch M
Circ Res; 2005 Aug; 97(3):227-35. PubMed ID: 16002749
[TBL] [Abstract][Full Text] [Related]
26. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior.
Holmes A; Yang RJ; Lesch KP; Crawley JN; Murphy DL
Neuropsychopharmacology; 2003 Dec; 28(12):2077-88. PubMed ID: 12968128
[TBL] [Abstract][Full Text] [Related]
27. Alcohol intake after serotonin transporter inactivation in mice.
Kelaï S; Aïssi F; Lesch KP; Cohen-Salmon C; Hamon M; Lanfumey L
Alcohol Alcohol; 2003; 38(4):386-9. PubMed ID: 12814910
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in mice.
Callebert J; Esteve JM; Hervé P; Peoc'h K; Tournois C; Drouet L; Launay JM; Maroteaux L
J Pharmacol Exp Ther; 2006 May; 317(2):724-31. PubMed ID: 16461587
[TBL] [Abstract][Full Text] [Related]
29. Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene.
Tjurmina OA; Armando I; Saavedra JM; Goldstein DS; Murphy DL
Endocrinology; 2002 Dec; 143(12):4520-6. PubMed ID: 12446578
[TBL] [Abstract][Full Text] [Related]
30. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.
Savale L; Tu L; Rideau D; Izziki M; Maitre B; Adnot S; Eddahibi S
Respir Res; 2009 Jan; 10(1):6. PubMed ID: 19173740
[TBL] [Abstract][Full Text] [Related]
31. Hyperplasia of pulmonary artery smooth muscle cells is causally related to overexpression of the serotonin transporter in primary pulmonary hypertension.
Eddahibi S; Humbert M; Fadel E; Raffestin B; Darmon M; Capron F; Simonneau G; Dartevelle P; Hamon M; Adnot S
Chest; 2002 Mar; 121(3 Suppl):97S-98S. PubMed ID: 11893722
[No Abstract] [Full Text] [Related]
32. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
Dempsie Y; Morecroft I; Welsh DJ; MacRitchie NA; Herold N; Loughlin L; Nilsen M; Peacock AJ; Harmar A; Bader M; MacLean MR
Circulation; 2008 Jun; 117(22):2928-37. PubMed ID: 18506000
[TBL] [Abstract][Full Text] [Related]
33. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.
Guignabert C; Raffestin B; Benferhat R; Raoul W; Zadigue P; Rideau D; Hamon M; Adnot S; Eddahibi S
Circulation; 2005 May; 111(21):2812-9. PubMed ID: 15927991
[TBL] [Abstract][Full Text] [Related]
34. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
[TBL] [Abstract][Full Text] [Related]
35. Absence of thermal hyperalgesia in serotonin transporter-deficient mice.
Vogel C; Mössner R; Gerlach M; Heinemann T; Murphy DL; Riederer P; Lesch KP; Sommer C
J Neurosci; 2003 Jan; 23(2):708-15. PubMed ID: 12533631
[TBL] [Abstract][Full Text] [Related]
36. Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.
Morecroft I; Dempsie Y; Bader M; Walther DJ; Kotnik K; Loughlin L; Nilsen M; MacLean MR
Hypertension; 2007 Jan; 49(1):232-6. PubMed ID: 17130306
[TBL] [Abstract][Full Text] [Related]
37. 5-HT-HPA interactions in two models of transgenic mice relevant to major depression.
Lanfumey L; Mannoury La Cour C; Froger N; Hamon M
Neurochem Res; 2000 Oct; 25(9-10):1199-206. PubMed ID: 11059794
[TBL] [Abstract][Full Text] [Related]
38. Impairment of hypoxic pulmonary artery remodeling by heparin in mice.
Hales CA; Kradin RL; Brandstetter RD; Zhu YJ
Am Rev Respir Dis; 1983 Oct; 128(4):747-51. PubMed ID: 6226226
[TBL] [Abstract][Full Text] [Related]
39. Serotonin regulates osteoclast differentiation through its transporter.
Battaglino R; Fu J; Späte U; Ersoy U; Joe M; Sedaghat L; Stashenko P
J Bone Miner Res; 2004 Sep; 19(9):1420-31. PubMed ID: 15312242
[TBL] [Abstract][Full Text] [Related]
40. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
